V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160013266 | 160006443 | 1.68 | 87.7 | Palliative (P) | 2017-10-22 | 2017-11-20 | null | N | N | TRIAL UNSPECIFIED | 100994507 |
| 160013268 | 160006444 | 1.67 | 79.2 | null | 2018-07-06 | 2018-07-14 | Cisplatin + Pemetrexed | 02 | N | STS RHABDO RMS 2005 VIN CYCLO | 101515380 |
| 160013269 | 160006445 | 1.51 | 65.1 | Palliative (P) | 2018-04-28 | 2018-04-28 | ETOP 13-18 BEAT-meso Trial | 02 | N | IVADO | 101807407 |
| 160013270 | 160006446 | 1.59 | 89.45 | 03 | 2017-07-05 | 2017-07-09 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101462330 |
| 160013271 | 160006447 | 1.76 | 69.5 | Palliative (P) | null | 2017-03-17 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101117579 |
| 160013272 | 160006448 | 1.58 | 74.9 | Palliative (P) | 2019-10-24 | 2019-10-25 | MELPHALAN | 02 | N | CISPLATIN + ETOPOSIDE | 100212241 |
| 160013275 | 160006449 | 1.7 | 53.7 | null | 2016-12-05 | 2016-12-05 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101500374 |
| 160013276 | 160006450 | 1.5 | 93.8 | null | 2016-04-13 | 2016-04-27 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 101588323 |
| 160013278 | 160006451 | 1.59 | 68.8 | Palliative (P) | 2017-02-28 | 2017-03-14 | DOXORUBICIN + IFOSFAMIDE | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101068961 |
| 160013280 | 160006452 | 1.58 | 103.2 | Palliative (P) | 2016-12-26 | 2017-01-02 | Pemetrexed | 02 | N | ABIRATERONE | 100811131 |
| 160013281 | 160006453 | 1.71 | 64 | Neo-adjuvant (N) | 2019-07-06 | 2019-07-06 | null | 02 | N | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 100472229 |
| 160013284 | 160006454 | null | null | Palliative (P) | 2018-11-11 | 2019-01-06 | Cisplatin + Pemetrexed | null | null | CISPLATIN + PEMETREXED | 100618557 |
| 160013285 | 160006455 | 1.7 | 70.55 | Curative (C) | null | 2016-07-03 | VAC | null | N | LIPOSOMAL DOXORUBICIN | 101219911 |
| 160013287 | 160006456 | 1.81 | 79.6 | Neo-adjuvant (N) | 2019-08-30 | 2019-09-02 | Cisplatin + Paclitaxel | 02 | 2 | PEMETREXED | 101247750 |
| 160013288 | 160006457 | 1.56 | 92 | Palliative (P) | null | 2019-06-02 | NB HRNBL-1 BUMEL MAT | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101730873 |
| 160013292 | 160006458 | null | 83.3 | null | 2019-12-28 | 2019-12-28 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101006896 |
| 160013293 | 160006459 | 1.62 | 67.3 | Palliative (P) | 2018-04-28 | 2018-05-11 | DOXORUBICIN | 02 | N | CARBOPLATIN + PACLITAXEL | 100545890 |
| 160013294 | 160006460 | 1.66 | 98.2 | Palliative (P) | 2017-07-11 | 2017-07-29 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100675949 |
| 160013295 | 160006461 | null | null | Palliative (P) | 2018-05-12 | 2018-05-12 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101088793 |
| 160013296 | 160006462 | 1.6 | 71.6 | Palliative (P) | 2018-12-29 | 2018-12-29 | Carboplatin + Paclitaxel (weekly) | N | N | CARBOPLATIN + PACLITAXEL | 100079234 |
| 160013297 | 160006463 | 1.56 | 56 | Curative (C) | 2017-09-21 | 2017-09-21 | GemCarbo Days 1+8 | 02 | N | DOXORUBICIN | 101126733 |
| 160013301 | 160006464 | 1.59 | 96 | Curative (C) | 2019-02-07 | 2019-02-07 | Trial Unspecified | N | N | DOXORUBICIN | 101445911 |
| 160013303 | 160006465 | 1.65 | 67 | Disease modification (D) | null | 2019-10-13 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100277779 |
| 160013306 | 160006466 | 1.74 | 75.9 | Neo-adjuvant (N) | 2018-05-05 | 2018-05-17 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101705567 |
| 160013307 | 160006467 | 0 | 91 | Curative (C) | 2016-05-21 | 2016-05-21 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101833862 |
| 160013308 | 160006468 | 1.52 | 77.9 | Palliative (P) | 2016-04-16 | 2016-04-20 | Etoposide + Ifosfamide (3 days) | 02 | N | DOXORUBICIN + OLARATUMAB | 101026243 |
| 160013309 | 160006469 | 1.51 | 70 | 03 | 2019-04-01 | 2019-04-03 | Trial Unspecified | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100370378 |
| 160013312 | 160006470 | 1.72 | 96 | Palliative (P) | 2020-09-02 | 2020-09-16 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | PACLITAXEL | 100871955 |
| 160013313 | 160006471 | 1.83 | 116.8 | Curative (C) | 2017-04-16 | 2017-04-18 | PACLITAXEL | 02 | N | EW EUROEWING 2012 ARM B VDC | 101053773 |
| 160013316 | 160006472 | 1.74 | 14 | Palliative (P) | 2018-07-03 | 2018-07-04 | Liposomal Doxorubicin (Caelyx) | 02 | null | TRIAL UNSPECIFIED | 101205907 |
| 160013318 | 160006473 | 1.75 | 72.9 | Curative (C) | 2019-12-03 | 2019-12-07 | Doxorubicin + Olaratumab | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100555808 |
| 160013319 | 160006474 | 1.67 | 66 | Palliative (P) | 2017-04-21 | 2017-05-03 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | N | CHOP R | 100011307 |
| 160013320 | 160006475 | 1.8 | 78.65 | Palliative (P) | 2019-07-08 | 2019-07-14 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101426540 |
| 160013321 | 160006476 | 1.7 | 59 | Neo-adjuvant (N) | 2016-12-16 | 2016-12-16 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100786486 |
| 160013322 | 160006477 | 1.5 | 79.3 | Neo-adjuvant (N) | 2017-02-17 | 2017-02-25 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100926441 |
| 160013326 | 160006478 | 1.68 | 79.1 | Palliative (P) | 2018-08-16 | 2018-08-23 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100760545 |
| 160013329 | 160006479 | 1.57 | 105.7 | Neo-adjuvant (N) | 2018-06-28 | 2018-06-29 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101863052 |
| 160013332 | 160006480 | 1.8 | 89.4 | Curative (C) | 2017-07-04 | 2017-07-17 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100642119 |
| 160013336 | 160006481 | 1.61 | 102 | Curative (C) | 2018-06-16 | 2018-07-19 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100640012 |
| 160013338 | 160006482 | 1.83 | 103 | Palliative (P) | 2022-03-08 | 2022-03-30 | Doxorubicin + Ifosfamide | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101018061 |
| 160013339 | 160006483 | 1.83 | null | Palliative (P) | 2016-01-27 | 2016-02-04 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 101060229 |
| 160013340 | 160006484 | 1.68 | 59.9 | Palliative (P) | 2020-02-04 | 2020-02-04 | VINCRISTINE | 01 | N | DOXORUBICIN + IFOSFAMIDE | 100897656 |
| 160013342 | 160006485 | 1.64 | 95.3 | Palliative (P) | 2018-08-05 | 2018-08-08 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101817793 |
| 160013344 | 160006486 | 1.78 | 83.9 | Palliative (P) | 2016-07-08 | 2016-08-01 | Abiraterone | 02 | N | VINORELBINE | 101474184 |
| 160013345 | 160006487 | 1.83 | 86.7 | Palliative (P) | 2019-11-22 | 2019-11-23 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 100698434 |
| 160013347 | 160006488 | 1.67 | 78.5 | Neo-adjuvant (N) | null | 2020-08-22 | Vinorelbine (oral) | 02 | N | EW EUROEWING 2012 ARM A VIDE | 100163521 |
| 160013348 | 160006489 | 1.79 | 70 | Palliative (P) | null | 2017-03-04 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 100375740 |
| 160013349 | 160006490 | 1.75 | 95.7 | Palliative (P) | 2016-12-31 | 2017-01-03 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101267932 |
| 160013350 | 160006491 | 1.63 | 73.35 | Curative (C) | 2019-09-20 | 2019-10-10 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101621945 |
| 160013353 | 160006492 | 1.55 | 66 | Palliative (P) | 2017-09-24 | 2017-09-25 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | DOXORUBICIN + IFOSFAMIDE | 100224197 |